The global pulmonary drug delivery technology market is projected to grow at a CAGR of approximately 5% over the next five years. This growth is driven by the rising prevalence of respiratory diseases ...
Among swallowed topical corticosteroids for eosinophilic oesophagitis (EoE), budesonide and fluticasone orodispersible tablets showed superior histologic efficacy, and budesonide inhalation devices ...